Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 91 for:    STORY autism
Previous Study | Return to List | Next Study

SynapDx Autism Gene Expression Analysis Study (STORY)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
SynapDx
ClinicalTrials.gov Identifier:
NCT01810341
First received: March 11, 2013
Last updated: December 15, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2014
  Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)